Curative Biosciences, Inc.
OTC: CBDX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Marcel Gamma
- Employees
- 6
- Headquarters
- Miami, United States
- IPO year
- 2004
- Market cap
- $25.8K
- Website
- http://www.curativebio.com
Loading CBDX…
Loading profile data…Frequently asked questions about CBDX
What does Curative Biosciences, Inc. (CBDX) do?
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 201...
Where does CBDX trade?
Curative Biosciences, Inc. (CBDX) trades on the Other OTC.
What sector is CBDX in?
Curative Biosciences, Inc. (CBDX) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Curative Biosciences, Inc.?
Marcel Gamma is the chief executive officer of Curative Biosciences, Inc. (CBDX).
Where is Curative Biosciences, Inc. headquartered?
Curative Biosciences, Inc. is headquartered in United States.
Does CBDX pay a dividend?
Curative Biosciences, Inc. (CBDX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CBDX go public?
Curative Biosciences, Inc. (CBDX) completed its initial public offering in 2004.